ComplianceOnline

FDA Issues Draft Guidance for Device Industry and Staff for Postmarket Surveillance – Overview and Summary of Recommendations

  • By: Staff Editor
  • Date: September 22, 2011
Webinar All Access Pass Subscription Abstract:

On August 16, 2011, the FDA issued draft guidance for the medical device industry and its own staff on how to conduct postmarket surveillance. This new guidance, when it is finalized, is expected to supersede the guidelines issued in 2006.

This article gives an overview of the new guidance and recommendations.

Bookmark and Share

Trending Compliance Trainings

You have a BI or Sterility Failure - Now What?
By - Gerry O Dell
On Demand Access Anytime
QA Agreements for ISO 13485:2019 and other Regulatory Compliance
By - Betty Lane
On Demand Access Anytime
Classifying Medical Devices - US and EU
By - Charles H Paul
On Demand Access Anytime
User / Human Factors Engineering Under IEC 62366-1, -2
By - John E Lincoln
On Demand Access Anytime
How to Interpret Probability Plots
By - Jerry Phillips
On Demand Access Anytime
Medical Device Software Verification and Validation
By - Nancy Knettell
On Demand Access Anytime
Overview of Medical Device Regulation in Europe
By - Rebecca Kemble
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading